A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19
Conditions: Covid19; SARS (Severe Acute Respiratory Syndrome); SARS-CoV Infection; SARS-CoV-2 Interventions: Biological: Biological: oral polio vaccine; Biological: Comparable Placebo; Drug: NA-831; Drug: Comparable Placebo of drug; Combination Product: Combination of oral polio vaccine and NA-831; Combination Product: Comparable Placebo of Oral Polio Vaccine and Placebo of dr ug Sponsors: NeuroActiva, Inc.; Biomed Industries, Inc. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials